Crystalline Management Inc. Horizon Therapeutics Public LTD CO Transaction History

Crystalline Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $1.47 Million - $1.72 Million	14,845 Added 37.11%	54,845 $6.35 Billion
Q2 2023 Aug 09, 2023	SELL	$96.34 - $112.38 $963,400 - $1.12 Million	-10,000 Reduced 20.0%	40,000 $4.11 Billion
Q1 2023 May 09, 2023	BUY	$107.32 - $113.5 $536,600 - $567,500	5,000 Added 11.11%	50,000 $5.49 Billion
Q4 2022 Mar 13, 2023	BUY	$62.39 - $113.8 $2.81 Million - $5.12 Million	45,000 New	45,000 $5.12 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Crystalline Management Inc., based on Form 13F filings with the SEC.

Stay updated on Crystalline Management Inc. with notifications on news.